Market Expansion Explore partnerships with similar companies like Exelixis and Blueprint Medicines, who have significant revenue and a larger workforce than Onkaido Therapeutics, potentially indicating a need for collaborative research or product development.

Financial Opportunities Due to reported revenue figures of comparable companies in the industry, engaging in discussions with Aeglea BioTherapeutics, IsoPlexis, and Harmony Biosciences could present opportunities for joint ventures or sales agreements that capitalize on their financial stability.

Technology Collaboration Assessing the tech stack utilized by Onkaido Therapeutics and seeking alignment with companies like Aeglea BioTherapeutics known for their innovative technologies could foster collaborations that leverage cutting-edge tools and methodologies for mutual product enhancement.

Geographic Exploration Given Onkaido Therapeutics' location in Spain, investigating potential expansion opportunities into the European market, possibly in conjunction with firms in the region like Blueprint Medicines, can open doors for new sales territories and increased market presence.

Strategic Partnerships Studying recent news and funding information related to Onkaido Therapeutics could reveal opportunities for strategic partnerships with investors or other companies aiming to support growing biotechnology ventures, leading to sales growth through shared resources.